Sawatani Medi Products India Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 07-12-2024
- Paid Up Capital ₹ 1.10 Cr
as on 07-12-2024
- Company Age 28 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.65 Cr
as on 07-12-2024
- Revenue %
(FY 2020)
- Profit 1997.05%
(FY 2020)
- Ebitda -1522.82%
(FY 2020)
- Net Worth 80.23%
(FY 2020)
- Total Assets -88.80%
(FY 2020)
About Sawatani Medi Products India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.10 Cr.
The company has closed loans amounting to ₹1.65 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Balakrishnan Rajendra and Jayanthi Rajendran serve as directors at the Company.
- CIN/LLPIN
U03311TZ1996PTC007466
- Company No.
007466
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sawatani Medi Products India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balakrishnan Rajendra  | Director | 01-Aug-1998 | Current |
| Jayanthi Rajendran | Director | 01-Apr-2013 | Current |
Financial Performance of Sawatani Medi Products India.
Sawatani Medi Products India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1997.05% increase in profit. The company's net worth Soared by an impressive increase of 80.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sawatani Medi Products India?
In 2020, Sawatani Medi Products India had a promoter holding of 58.25% and a public holding of 41.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sawatani Rubbers India Private LimitedActive 29 years 2 monthsBalakrishnan Rajendra and Jayanthi Rajendran are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Nedungadi Bank Ltd. Creation Date: 30 Apr 1999 | ₹7.00 M | Satisfied |
Small Industries Development Bank Of India Creation Date: 12 Sep 1997 | ₹9.50 M | Satisfied |
How Many Employees Work at Sawatani Medi Products India?
Unlock and access historical data on people associated with Sawatani Medi Products India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sawatani Medi Products India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sawatani Medi Products India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
